Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema

Mastectomy; Lymphedema Clinical Trial

Official title:

Endermologie Versus Negative Pressure Therapy on Postmastectomy Lymphedema

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05761353
• Other study ID #: P.T.REC/012/003744
• Status: Completed
• Phase: N/A
• Start date: June 29, 2022
• Est. completion date: October 30, 2023

Study information

• Verified date: December 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Statement of the problem:

The problem will be stated in a questionary form:

"Which will be more effective endermologie or negative pressure therapy in reducing limb circumference and volume in postmastectomy lymphedema?".

Hypothesis:

It will be hypothesized that:

There is no significant difference between endermologie and negative pressure therapy in reducing circumference and limb volume in post mastectomy lymphedema.

Description:

Subject:

Sixty- eight women treated for unilateral breast cancer with secondary upper limb lymphedema post mastectomy will participate in this study. Their ages will be ranged from 40 to 60 years, they will be free from any other diseases that will affect or influence the results and the participants will be selected from National Cancer Institute and randomly distributed into two equal groups in number.

Study design:

In this study the patients will be randomly assigned into two groups equal in number (34 patients for each group).

Inclusion Criteria:

The subject selection will be according to the following criteria:

• Only females will participate in the study.

• Patients' age will be ranged between 40-60 years.

• All patients will suffer from post mastectomy lymph-edema.

• All patients have a modified radical mastectomy.

• All patients will suffer from grade II lymph edema without skin changes one year post mastectomy.

• All patients are right-dominant hand.

• All patients enrolled to the study have their informed consent.

Exclusion Criteria:

The potential participants will be excluded if they meet one of the following criteria:

• primary lymph-edema.

• Diabetes mellitus.

• Pregnancy.

• Recurrent cancer.

• Current or recent cellulitis.

• Current metastases.

• Venous thrombosis.

• Photosensitivity.

• Phlebitis in development stage.

• Infection.

• Receiving anti-coagulant treatment.

Equipment:

The study equipment's will be divided into measurement and therapeutic equipment and tools:

1: Measurement equipment

1(a):Limb volume measurement:

This will be performed by measuring the circumference of each segment of the limb between two consecutive circumferences as a truncated zone. The volume of the segment was calculated as:

V=h (c12+c1c2+c22 )/12π, where V is the volume of the segment, c1 and c2 are the circumferences at the ends of the segment, and h is the distance between them.

Measurement of limb volume measurement will be conducted pre-treatment and after treatment course (6 weeks).

1. (b): Measuring Disability of the arm, shoulder and hand by: .Quick DASH questionnaire (Disability of the arm, shoulder, and hand).

• The Quick- DASH has five response options for each item from 0=no difficulty to perform or no symptoms to 5=unable to do.

• Quick DASH scale will be conducted pre-treatment and after treatment course (6 weeks).

2. Therapeutic equipment :

2. a. Endermologie: endermologie therapy will be three sessions per week for six weeks (total 18 sessions).

The study group will receive 18 sessions by Endermologie system ( used to decrease postmastectomy lymphedema for group (A), three sessions per week for six weeks.

Each session was 30 minutes at the posterior thorax, upper arm, forearm and the hand.

2.b. Negative pressure therapy:

• Pressure: 20-250 mm Hg.

• Total treatment period: six weeks.

• A number of sessions: 3 sessions/ week. Time of application : 30 min

Recruitment information / eligibility

• Status: Completed
• Enrollment: 68
• Est. completion date: October 30, 2023
• Est. primary completion date: June 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 40 Years to 60 Years

Eligibility

Inclusion Criteria:

• Only females will participate in the study.

• Patients' age was ranged between 40-60 years.

• All patients will suffer from post mastectomy lymphedema.

• All patients have a modified radical mastectomy.

• All patients suffer from grade II lymphedema without skin changes one year post mastectomy(as defined by the International Society of Lymphology).

• All patients are right-dominant hand.

• All patients enrolled to the study will have their informed consent.

Exclusion Criteria:

• The potential participants will be excluded if they meet one of the following criteria:

• primary lymphedema.

• Diabetes mellitus.

• Pregnancy.

• Recurrent cancer.

• Current or recent cellulitis.

• Current metastases.

• Venous thrombosis.

• Photosensitivity.

• Phlebitis in development stage.

• Infection.

• Receiving anti-coagulant treatment.

Related Conditions & MeSH terms

• Breast Cancer Lymphedema
• Lymphedema
• Mastectomy; Lymphedema

Intervention

Device:
• Endermologie
Group A will receive -18 sessions by Endermologie system used to decrease postmastectomy lymphedema for group (A), three sessions per week for six weeks. Each session was 30 minutes at the posterior thorax, upper arm, forearm and the hand. -In addition to physical therapy program (active range of motion and elevation); hygiene and skin care
• Negative pressure therapy
Group B will receive negative pressure therapy with Pressure: 20-250 mmHg. Total treatment period: 6weeks A number of sessions: 3sessions/ week. Time of application : 30 min In addition to physical therapy program (active range of motion and elevation); hygiene and skin care

Locations

Country	Name	City	State
Egypt	Outpatient clinic, Faculty of Physical Therapy, Cairo university	Giza	Dokki

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measuring Disability of the arm, shoulder and hand	Measuring Disability of the arm, shoulder and hand will be carried out by using Quick-DASH questionnaire	Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb function before and after treatment
Primary	Limb volume measurement	Limb volume measurement will be carried out by by measuring the circumference of each segment of the limb between two consecutive circumferences as a truncated zone. The volume of the segment was calculated as: V=h (c1+c1c2+c2 )/12p	Measuring will be taken before treatment and after 6 weeks of treatment to monitor the change in upper limb volume and decrease of lymph-edema